» Articles » PMID: 25750095

[Standardization of Spirometry: 2015 Update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine]

Overview
Journal Pneumologie
Publisher Thieme
Specialty Pulmonary Medicine
Date 2015 Mar 10
PMID 25750095
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Spirometry is a simple test and considered the gold standard in lung function. An obstructive ventilatory defect is a disproportionate reduction of maximal airflow from the lung in relation to the maximal volume that can be displaced from the lung. It implies airway narrowing and is defined by a reduced FEV1/FVC ratio below the 5th percentile of the predicted value (lower limit of normal, LLN). A restrictive disorder may be suspected when vital capacity (FVC) is reduced and FEV1/FVC is normal. It is definitely proven, however, only by a decrease in TLC below the 5th percentile of predicted value (LLN). The measurement of TLC by body plethysmography is necessary to confirm or exclude a restrictive defect or hyperinflation of the lung when FVC is below the LLN. 2012 a task force of the ERS published new reference values based on 74,187 records from healthy non-smoking males and females from 26 countries. The new reference equations for the 3-95 age range are now available that include appropriate age-dependent mean values and lower limits of normal (LLN). This presentation aims at providing the reader with recommendations dealing with standardization and interpretation of spirometry.

Citing Articles

Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET.

Alter P, Kahnert K, Trudzinski F, Bals R, Watz H, Speicher T Int J Chron Obstruct Pulmon Dis. 2024; 19():2629-2638.

PMID: 39655060 PMC: 11626970. DOI: 10.2147/COPD.S475112.


Improvement of pulmonary function parameters in female patients with adolescent idiopathic scoliosis by Schroth rehabilitative therapy.

Stein K, Holzgreve F, Keil F, Diaremes P, Groneberg D, Wanke E Heliyon. 2024; 10(15):e34758.

PMID: 39166021 PMC: 11333894. DOI: 10.1016/j.heliyon.2024.e34758.


Pulmonary function in patients with ANCA-associated vasculitis.

Dieterich J, Hellmich B, Mahrhold J, Feng Y, El Rai A, Nessyt F Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(2):e2024025.

PMID: 38940708 PMC: 11275547. DOI: 10.36141/svdld.v41i2.15577.


Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study.

Hoppner J, Wollsching-Strobel M, Schumacher F, Windisch W, Berger M Arch Rheumatol. 2024; 39(1):46-51.

PMID: 38774704 PMC: 11104760. DOI: 10.46497/ArchRheumatol.2024.10105.


GLI-12 Reference Values versus Fixed 0.7 Ratio for the Detection of Airflow Obstruction in the Presence of Lung Hyperinflation.

Wahab L, Cornelissen C, Windisch W, Dreher M Biomed Hub. 2024; 9(1):16-24.

PMID: 38264215 PMC: 10805410. DOI: 10.1159/000535507.